BridgeMD
New treatment option for Advanced Malignant Solid Neoplasm
Official title Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
ClinicalTrials.gov ID: NCT04984551
What this study is testing
- What it's testing
- This trial investigates the experience and satisfaction of care in patients with cancer that has spread to other places in the body (advanced) and their caregivers living in underserved areas of Kenya, Nigeria, Ghana, South Africa, India and Ethiopia as part of Project Extension for Community Healthcare Outcomes (ECHO). Project ECHO is a model of medical education and care management that empowers clinicians to provide better care to more people where they live.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults. Healthy volunteers may be eligible.
You may be able to join if
- PATIENT: Scheduled to receive treatment at participating primary care practice for advanced cancer
- PATIENT: 18 years or older
- PATIENT: Willing to be accessible to the research team for follow-up by telephone or in person
- PATIENT: Prognosis of at least 1 year as ascertained by the treating physician
- PATIENT: Able to read and understand English as assessed by the treating physician
You likely can't join if
- Unable to understand and sign consent
See the full eligibility criteria
- PATIENT: Scheduled to receive treatment at participating primary care practice for advanced cancer
- PATIENT: 18 years or older
- PATIENT: Willing to be accessible to the research team for follow-up by telephone or in person
- PATIENT: Prognosis of at least 1 year as ascertained by the treating physician
- PATIENT: Able to read and understand English as assessed by the treating physician
- CAREGIVER: Identified or self-identified as primary caregiver of the patient
- CAREGIVER: Willing to be accessible to the research team for follow-up by telephone or in person
- CAREGIVER: 18 years or older
- CAREGIVER: Able to read and understand English as assessed by the treating physician
- ECHO PARTICIPANT: Participant must be a health care provider interested to participate in the study for 2 years and understand the protocol and provide consent
- ECHO PARTICIPANT: Able to read and understand English as assessed by principal investigator (PI)
- Unable to understand and sign consent
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.